Harvesting Cells for Experimental Cancer Treatments

Enrolling by invitationOBSERVATIONAL
Enrollment

7,000

Participants

Timeline

Start Date

September 8, 2003

Conditions
MelanomaGastrointestinal CancerMetastatic CancerBreast CancerNon-Small Cell Lung Cancer
Interventions
DRUG

Anti-CD19 CAR PBL

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH